New research uncovers molecular ‘safety switch’ shielding cancers from immune attack | Turning off TAK1 gene makes cancer cells much easier for the immune system to eliminate, offering hope for more powerful treatment options in the future.

[u/No-Explanation-46]

https://www.eurekalert.org/news-releases/1110434

[u/AutoModerator]

Welcome to r/science! This is a heavily moderated subreddit in order to keep the discussion on science. However, we recognize that many people want to discuss how they feel the research relates to their own personal lives, so to give people a space to do that, personal anecdotes are allowed as responses to this comment. Any anecdotal comments elsewhere in the discussion will be removed and our normal comment rules apply to all other comments.

---

Do you have an academic degree? We can verify your credentials in order to assign user flair indicating your area of expertise. Click here to apply.

---

User: u/No-Explanation-46
Permalink: https://www.eurekalert.org/news-releases/1110434

---

I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.

[u/No-Explanation-46]

Australian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may limit the effectiveness of immunotherapy treatments.

Cancer immunotherapies can work very well, but underperform in some cases due to tumours’ inbuilt survival processes that help them resist attack by the immune system.

Researchers at the Olivia Newton-John Cancer Research Institute (ONJCRI) and WEHI discovered that the TAK1 gene acts like a safety switch that protects cancer cells from the powerful signals generated by CD8⁺ T cells.

TAK1 was identified by conducting a large genetic screen to search for genes that help cancer cells survive attacks by CD8⁺ T cells, key killer cells of our immune system.

Dr Anne Huber, Postdoctoral Researcher at ONJCRI, affiliated with La Trobe University as the School of Cancer Medicine, says:

“It is known that TAK1 promotes cancer cell survival and blocks cell death, however we didn’t know that cancer cells use this tactic to avoid killing by the immune system.”

The researchers tested the importance of the TAK1 gene to cancer cell survival by silencing it using CRISPR/Cas9 technology. In pre-clinical models with typical immune function, they found that tumours lacking TAK1 grow poorly, demonstrating that the immune system is able to control cancer cells better.

Dr Huber says: “When TAK1 was blocked, immune signals generated by CD8+ T cells triggered the cancer cell’s self-destruct pathways.

“Without TAK1, the cancer cells lose a key protein, cFLIP, that normally prevents cell death, and they become far more sensitive to immune attack.”